Takeda Pharmaceutical shares fell 7.4% to their lowest level in more than a year, over concerns that the potential blockbuster deal to acquire Shire was too much for the Japanese company to swallow.
from WSJ.com: US Business https://ift.tt/2GWgunK
via IFTTT
No comments:
Post a Comment